You’ve probably heard some version of this: operators who accept Medicaid are going to get hurt by the 2027 coverage losses. That framing is close enough to feel true, and wrong enough to drive bad decisions.
Medicaid acceptance and Medicaid concentration are different things. Operators know this intuitively. Most of the analysis being written for investors doesn’t reflect it.
Federal Medicaid changes start biting in late 2026, and the largest coverage losses land in January 2027. That gives this distinction real teeth.
The current context
The 2025 federal legislation cut roughly $1 trillion in Medicaid spending over ten years — the biggest rollback in the program’s history. Somewhere between 10 and 12 million people are projected to lose coverage. Work requirements and new administrative verification will push more people off the rolls beyond the headline number.
Treatment absorbs more of this than most sectors. Medicaid is the single largest payer for substance use disorder treatment in the country, and it’s not close. Penn’s Leonard Davis Institute projects the overdose death rate could double among people cut from Medicaid-funded SUD programs.
In New York alone, the Center for American Progress estimates 166,500 Medicaid enrollees currently in SUD programs will lose coverage. Every state with a meaningful Medicaid SUD population is looking at some version of this.
Operators already know the scale. What’s less obvious is how differently the exposure lands on different operators — and which parts of a treatment business determine where any given one sits on that spectrum.
Acceptance vs. concentration
Two decisions shape an operator’s payer mix, and they’re mostly independent of each other.
The first is which payers you accept. That’s the contracts, the credentialing, the billing stack, the prior auth workflows. Accepting Medicaid means you’ve built the operational capacity to serve Medicaid patients — in-network agreements, state-specific compliance, the full apparatus.
The second is which payers you actually concentrate around. That one shows up in service design, facility standards, staffing ratios, marketing spend, and which referral sources you cultivate. An operator concentrated on Medicaid has calibrated their whole economic model to Medicaid reimbursement rates.
Both of these operators accept Medicaid. They’re running fundamentally different businesses.
How operators cluster
In practice, operators cluster in roughly three ways, and the boundaries between them aren’t clean.
The first group accepts Medicaid but runs the revenue engine on commercial, private-pay, and Medicare. Medicaid admissions are there as census stabilization when commercial volume dips, and to keep state and county referral relationships intact. Medicaid typically sits at 15–35% of revenue.
The second is a balanced-mix posture — Medicaid, commercial, and Medicare roughly proportional. Facility design and service offerings have to accommodate multiple payer expectations simultaneously, which creates its own operational overhead. Medicaid usually lands somewhere between 35% and 55% of revenue.
The third group is Medicaid-first. These operators built staffing ratios, facility standards, and pricing assumptions around Medicaid reimbursement economics. Their margins require Medicaid volume. Their commercial leverage is limited because their cost structure is already calibrated to state rate schedules. Medicaid is 55%+ of revenue, and for some it’s north of 80%.
Why 2027 hits these groups asymmetrically
Everyone takes some damage. The question is structural versus cyclical.
For the floor-coverage operators, the hit is volume. Fewer Medicaid-covered patients, fewer Medicaid admissions, some pressure on census. Commercial and private-pay absorb more of the total, often at better margin per admission. Marketing spend may have to rise to replace the lost Medicaid volume with commercial volume, but the business model itself doesn’t break. The mix drifts at the edges.
For balanced-mix operators, it’s harder. Medicaid revenue falls in absolute terms, which has to be replaced. Replacing it means accelerating commercial and private-pay acquisition, which usually means service upgrades, marketing investment, and sometimes facility work to meet commercial payer expectations. The economic model flexes. It doesn’t break, but recovery takes capital and management attention the operator may not have slack for.
For Medicaid-first operators, the exposure is structural. Their economics don’t work at reduced Medicaid rates. Their facilities aren’t calibrated for commercial-grade service expectations. Their referral networks are state-and-county-heavy with thin commercial payer relationships. Shifting payer mix isn’t a marketing decision. It’s a multi-year operational rebuild — reinvestment, rebranding, often workforce restructuring. Some operators will get through the transition. Others won’t.
What this changes for PE diligence
This distinction is getting louder in how sophisticated investors evaluate treatment opportunities in 2026. “Medicaid acceptance rate” as a single line item is losing its signal value.
The diligence questions we’re hearing now:
- What percentage of the operator’s revenue is Medicaid-primary, not just Medicaid-accepted?
- What happens to EBITDA if state Medicaid rates drop 15–20%?
- How quickly could the operator shift payer mix if they had to, and what would it cost?
- How much of the referral base is state and county agencies that will see their own funding pressure?
Operators who can answer these cleanly are negotiating from a stronger position. Operators who can’t — and that’s more of them than most investors realize — are running exposed regardless of what the Medicaid acceptance number says on the tear sheet.
What operators should be doing now
Know your actual concentration first. “We accept Medicaid” and “40% of our revenue is Medicaid-primary” are two different statements, and the second one is the one that matters. Most operators have this intuitively. Fewer have it broken out by location, service line, and admission source on a quarterly basis, which is where the useful conversation starts.
Next, stress-test the margin structure. Run financials against 10%, 15%, and 20% Medicaid rate reductions. If EBITDA falls materially in any of those scenarios, there’s concentration risk sitting underneath the reported payer mix regardless of what the headline percentage looks like.
And build optionality before you need it. Operators with existing commercial payer relationships, working private-pay intake infrastructure, and Medicare capability have more paths available than operators optimized purely for Medicaid volume. Putting those relationships in place now, while you’re not in crisis mode, is dramatically cheaper than putting them in place later.
Where GTH Intelligence fits
Getting payer mix concentration right at the market level means cross-referencing facility registry data against state Medicaid reimbursement schedules, payer-mix patterns by geography, and operator footprint. That’s the analytical work we do at GTH Intelligence.
Over the coming weeks we’ll be publishing state-level Medicaid concentration analyses drawn from SAMHSA registry data and state reimbursement schedules. If you’re an operator or investor and you want a specific state breakdown, reach out: partners@gettreatmenthelp.com.
The treatment sector is navigating the biggest payer environment shift in a decade. The operators who understand the structural distinctions driving exposure are going to be the ones in position to manage it.
— GTH Team